Resultados de la búsqueda 81-90 of 1607 for Secondary

  1. Hipertensión secundaria - Médicos y departamentos - Mayo Clinic

    Obtén más información acerca de la hipertensión arterial provocada por otra afección médica. Infórmate sobre los factores de riesgo y tratamientos para ...

  2. Neurología - Ensayos clínicos - Mayo Clinic

    ... secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme (GBM) which often displays the ...

  3. Neurología - Ensayos clínicos - Mayo Clinic

    ... secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme (GBM) which often displays the ...

  4. Neurología - Ensayos clínicos - Mayo Clinic

    ... secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme (GBM) which often displays the ...

  5. Neurología - Ensayos clínicos - Mayo Clinic

    Data from this natural history study will be used to determine a set of clinical and biological parameters that will be used for primary and secondary ...

  6. Neurología - Ensayos clínicos

    ... secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme (GBM) which often displays the ...

  7. Neurología - Ensayos clínicos - Mayo Clinic

    ... secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme (GBM) which often displays the ...

  8. Dermatología - Ensayos clínicos - Mayo Clinic

    The secondary objectives of the study is to compare the overall survival (OS) of high-risk CSCC patients treated with adjuvant cemiplimab, versus those ...

  9. Radiología - Ensayos clínicos - Mayo Clinic

    The secondary purpose is to initiate a data registry for the PET/MR studies allowing us to capture some basic information about the indications, findings ...

  10. Cirugía - Ensayos clínicos - Mayo Clinic

    The secondary objectives of the study is to compare the overall survival (OS) of high-risk CSCC patients treated with adjuvant cemiplimab, versus those ...